Peng-Da Guo

835 total citations
18 papers, 644 citations indexed

About

Peng-Da Guo is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Peng-Da Guo has authored 18 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Peng-Da Guo's work include Cancer Mechanisms and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Autophagy in Disease and Therapy (2 papers). Peng-Da Guo is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Autophagy in Disease and Therapy (2 papers). Peng-Da Guo collaborates with scholars based in China, United States and Brazil. Peng-Da Guo's co-authors include Xing-Xing Lu, Jianming Li, Wen-Juan Gan, Jingru Wang, Quansheng Zhou, Hua Wu, Gaochuan Zhang, Xiu‐Ming Li, Yanyan Pan and Zhifei Cao and has published in prestigious journals such as Blood, Cancer Research and International Journal of Pharmaceutics.

In The Last Decade

Peng-Da Guo

18 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng-Da Guo China	13	382	144	140	93	91	18	644
Yuhao Luo China	16	644 1.7×	377 2.6×	137 1.0×	57 0.6×	67 0.7×	40	934
Xiaonan Xi China	11	279 0.7×	157 1.1×	79 0.6×	93 1.0×	53 0.6×	15	501
Begoña Cánovas Spain	6	432 1.1×	94 0.7×	125 0.9×	39 0.4×	76 0.8×	8	677
Tong Han China	15	364 1.0×	214 1.5×	72 0.5×	100 1.1×	28 0.3×	32	555
Ae Jin Jeong South Korea	10	308 0.8×	106 0.7×	168 1.2×	30 0.3×	72 0.8×	19	586
Juan Yan China	11	386 1.0×	121 0.8×	78 0.6×	39 0.4×	79 0.9×	24	565
Giorgia Colombo Italy	11	256 0.7×	113 0.8×	197 1.4×	48 0.5×	124 1.4×	24	611
Yingchun He China	11	296 0.8×	149 1.0×	76 0.5×	45 0.5×	41 0.5×	35	493
Chengzhi Xie China	16	682 1.8×	57 0.4×	177 1.3×	147 1.6×	41 0.5×	24	1.0k

Countries citing papers authored by Peng-Da Guo

Since Specialization

Citations

This map shows the geographic impact of Peng-Da Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng-Da Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng-Da Guo more than expected).

Fields of papers citing papers by Peng-Da Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng-Da Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng-Da Guo. The network helps show where Peng-Da Guo may publish in the future.

Co-authorship network of co-authors of Peng-Da Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Peng-Da Guo. A scholar is included among the top collaborators of Peng-Da Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng-Da Guo. Peng-Da Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Qian, Dandan Jiang, Shasha Zhang, et al.. (2025). Light-activated photosensitizer/quercetin co-loaded extracellular vesicles for precise oral squamous cell carcinoma therapy. International Journal of Pharmaceutics. 671. 125224–125224. 2 indexed citations

Guo, Peng-Da, Yang Yang, Lu Wang, et al.. (2024). Development of a streamlined NGS-based TCGA classification scheme for gastric cancer and its implications for personalized therapy. Journal of Gastrointestinal Oncology. 15(5). 2053–2066. 2 indexed citations

Chen, Liquan, et al.. (2020). Effect of Hot Deformation Parameters on the Evolution of Microstructure and Texture of β Phase in TC18 Titanium Alloy. Acta Metallurgica Sinica. 57(7). 880–890. 1 indexed citations

Zhang, Ming, Yi Ru, Shasha Zhang, et al.. (2020). A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma. International Journal of Molecular Medicine. 46(1). 252–264. 23 indexed citations

Wu, Hua, Xing-Xing Lu, Jingru Wang, et al.. (2019). TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation. Autophagy. 15(9). 1506–1522. 105 indexed citations

Guo, Peng-Da, et al.. (2018). Clinicopathological analysis of PD-L2 expression in colorectal cancer. OncoTargets and Therapy. Volume 11. 7635–7642. 20 indexed citations

Shen, Tong, Yuhong Liu, Shi Li, et al.. (2018). Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy. Journal of Hematology & Oncology. 11(1). 95–95. 80 indexed citations

Guo, Peng-Da, Xing-Xing Lu, Wen-Juan Gan, et al.. (2016). RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo–Yap Pathway. Cancer Research. 76(13). 3813–3825. 48 indexed citations

Li, Xiuming, Shen Zhang, Xiao‐Shun He, et al.. (2016). Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice. Journal of Inflammation. 13(1). 4–4. 23 indexed citations

10.

Gan, Wen-Juan, Jingru Wang, Xiao‐Shun He, et al.. (2016). RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis. Journal of Experimental & Clinical Cancer Research. 35(1). 164–164. 24 indexed citations

11.

Cheng, Xing, Xing-Xing Lu, Peng-Da Guo, et al.. (2015). Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis. Cancer Research. 76(1). 83–95. 79 indexed citations

12.

Li, Xiu‐Ming, Xing-Xing Lu, Qian Xu, et al.. (2015). Nur77 deficiency leads to systemic inflammation in elderly mice. Journal of Inflammation. 12(1). 40–40. 29 indexed citations

13.

Cao, Zhifei, Di Yu, Gaochuan Zhang, et al.. (2013). Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicology Letters. 218(2). 174–185. 89 indexed citations

14.

Zhang, Gaochuan, Ping Yang, Peng-Da Guo, et al.. (2013). Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1836(1). 49–59. 28 indexed citations

15.

Liu, Ruifang, Zhifei Cao, Yanyan Pan, et al.. (2013). Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. Anti-Cancer Drugs. 24(7). 667–676. 40 indexed citations

16.

Guo, Peng-Da, et al.. (2013). Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression. Current Cancer Drug Targets. 13(9). 996–1011. 8 indexed citations

17.

Tu, Jian, Zhifei Cao, Yanyan Pan, et al.. (2012). Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells. Leukemia & lymphoma. 53(12). 2456–2464. 42 indexed citations

18.

Zhou, Quansheng, Zhifei Cao, Meimei Bao, et al.. (2011). The Molecular and Cellular Processes of Tumor Cell-Mediated Tumor Angiogenesis and Vasculogenesis,. Blood. 118(21). 3267–3267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact